Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis.
Sysojev AÖ, Saevarsdottir S, Diaz-Gallo LM, Silberberg GN, Alfredsson L, Klareskog L, Baecklund E, Björkman L, Kastbom A, Rantapää-Dahlqvist S, Turesson C, Jonsdottir I, Stefansson K, Frisell T, Padyukov L, Askling J, Westerlind H.
Sysojev AÖ, et al. Among authors: askling j.
Rheumatology (Oxford). 2024 May 2;63(5):1221-1229. doi: 10.1093/rheumatology/kead301.
Rheumatology (Oxford). 2024.
PMID: 37326842
Free PMC article.
METHODS: We conducted a genome-wide association study (GWAS) in a sample of 3902 Swedish early-RA patients initiating MTX in DMARD monotherapy as their first-ever DMARD. The outcome, short- and long-term MTX treatment persistence, was defined as remaining on MTX at 1 and a …
METHODS: We conducted a genome-wide association study (GWAS) in a sample of 3902 Swedish early-RA patients initiating MTX in DMARD monothera …